Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02810327 · ClinicalTrials.gov registry record
Alpha-1 Carrier Genomics Study
A clinical trial of Smoking and COPD, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 117
- Enrollment target
- 1
- Study location
NCT02810327 is a study of Smoking and COPD that has completed, run by Medical University of South Carolina. The registered enrollment target is 117 participants, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02810327, a study of Smoking and COPD, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to better understand why some Alpha-1 genotype MZ (PiMZ) individuals develop chronic obstructive pulmonary disease (COPD) while others do not. This study will examine portions of the Alpha-1 gene that are not routinely tested to determine whether other changes in this gene correlate with development and progression of COPD. Participation involves responding to questionnaires about lung health and history, and performing an at-home finger stick to obtain blood spots using a test kit that is mailed. The blood provided will be used for genetic testing and correlation of results with COPD history. Participants will receive their results and access to genetic counseling at the conclusion of the study.
Conditions Studied
Interventions
- GENETIC Genetic Sequencing
Study Locations (1)
South Carolina
- Medical University of South Carolina. Division of Pulmonary and Critical Care Medicine - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02810327
The ClinicalTrials.gov registry entry for NCT02810327 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (74% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which Genetic Sequencing is the first listed.
NCT02810327 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT02810327 about?
NCT02810327 is a clinical study titled "Alpha-1 Carrier Genomics Study". The goal of this study is to better understand why some Alpha-1 genotype MZ (PiMZ) individuals develop chronic obstructive pulmonary disease (COPD) while others do not. This study will examine portions of the Alpha-1 gene that are not routinely tested to determine whether other changes in this gene ...
What is the current status of trial NCT02810327?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2015-02. Estimated completion is 2017-04.
What conditions does trial NCT02810327 study?
This clinical trial studies the following conditions: Smoking, COPD, Emphysema, Alpha-1 Antitrypsin Deficiency.
What interventions are being tested in trial NCT02810327?
The interventions under investigation include: Genetic Sequencing (GENETIC).
Who is sponsoring clinical trial NCT02810327?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02810327 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Integrating Financial Coaching and Smoking Cessation Coaching
RECRUITING · Phase 3
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.